Group/Characteristics | RAPd | RA | Pd | HC | p-value |
---|---|---|---|---|---|
(n = 20) | (n = 20) | (n = 20) | (n = 20) |  | |
Mean age (years) | 54.3 ± 7.5 | 52.7 ± 9.5 | 44.0 ± 11.6 | 39.6 ± 11.5 | ** < 0.00a |
Mean ESR (mm/hr) | 32.8 ± 21.4 | 27.9 ± 11.6 | N/A | N/A | 0.379b |
 | n (%) | n (%) | n (%) | n (%) |  |
Gender | Â | Â | Â | Â | Â |
Female | 14 (70) | 19 (95) | 11 (55) | 16 (80) | **0.028c |
Male | 6 (30) | 1 (5) | 9 (45) | 4 (20) | |
Ethnicity | Â | Â | Â | Â | Â |
Malay | 4 (20) | 7 (35) | 9 (45) | 13 (65) | 0.086c |
Chinese | 11 (55) | 7 (35) | 9 (45) | 5 (25) | |
Indian | 5 (25) | 6 (30) | 2 (10) | 2 (10) | |
Educational level | Â | Â | Â | Â | Â |
Tertiary | 6 (30) | 13 (65) | 13 (65) | 18 (90) | 0.050c |
Secondary | 14 (70) | 6 (30) | 7 (35) | 2 (10) | |
Primary | 0 (0) | 1 (5) | 0 (0) | 0 (0) | |
Smoking status | Â | Â | Â | Â | Â |
Smoker | 2 (10) | 0 (0) | 3 (15) | 3 (15) | 0.457c |
Former smoker | 2 (10) | 0 (0) | 1 (5) | 1 (5) | |
Non-smoker | 16 (80) | 20 (100) | 16 (80) | 16 (80) | |
RA disease duration | Â | Â | Â | Â | Â |
 < 5 | 8 (40) | 7 (35) | N/A | N/A | 0.587c |
5–10 | 6 (30) | 9 (45) | N/A | N/A | |
 > 10 years | 6 (30) | 4 (20) | N/A | N/A | |
RA medication Corticosteroid NSAIDs Conventional DMARDs Biologic DMARDs Combination | 1(5) 3(15) 7(35) 0(0) 6(30) | 0(0) 2(10) 9(40) 1(5) 5(25) | N/A N/A N/A N/A N./A | N/A N/A N/A N/A N/A | 0.632c |
PD status | Â | Â | Â | Â | Â |
Localised Pd | 17 (85) | N/A | 14 (70) | N/A | 0.110c |
Generalised Pd | 3 (15) | N/A | 6 (30) | N/A |